CIK 0001997296 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Medicus Pharma Ltd.
Sign in to watch- Ticker
- MDCX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ontario, Canada
- Entity type
- operating
- EIN
- 981778211
- Phone
- 610-540-7515
- Business address
- 300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PA, 19428
Securities
- MDCX Common Stock Nasdaq
- MDCXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Smith Andrew Alasdair Chief Operating Officer | Grant or award | +735,294 | $0.17 | $125K | 735,458 |
| 2026-09-04 | Smith Andrew Alasdair Chief Operating Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2026-09-04 | Mehmud Faisal Chief Medical Officer | Grant or award | +1,470,588 | $0.17 | $251K | 1,470,588 |
| 2026-09-04 | Mehmud Faisal Chief Medical Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2026-09-04 | Brennan Edward J. Chief Scientific Officer | Grant or award | +588,235 | $0.17 | $100K | 674,735 |
| 2026-09-04 | Brennan Edward J. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-09-04 | Bonner Carolyn F. President and CFO | Grant or award | +1,470,588 | $0.17 | $251K | 1,489,493 |
| 2026-09-04 | Bonner Carolyn F. President and CFO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2026-09-04 | Bokhari Raza Chief Executive Officer | Grant or award | +2,941,176 | $0.17 | $501K | 2,941,176 |
| 2026-09-04 | Bokhari Raza Chief Executive Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2026-06-03 | Smith Andrew Alasdair Chief Operating Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2026-06-03 | Rodgers Cathy McMorris Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Raju Ajay Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Mehmud Faisal Chief Medical Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2026-06-03 | May Sara R. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | MAHAFFY PATRICK J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Kaiser Larry Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | FISHMAN BARRY Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Ciaruffoli Robert J. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-06-03 | Brennan Edward J. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 |
Page 1 of 4 · 65 trades